酪蛋白源ACE抑制肽的精制

采用离子交换树脂对酪蛋白源ACE抑制肽进行脱盐处理,结果表明,以10倍柱体积/h流速,经阴阳离子交换树脂后脱盐率达80%左右,氮回收率为83%,脱盐处理前后基本上对其ACE抑制活性和氨基酸含量没有影响。     

Angiotensin-I-converting enzyme (ACE)-inhibitory peptides from Thai jasmine rice bran protein hydrolysates

Rice bran protein hydrolysate (<50 kDa RBPH) from Thai jasmine variety demonstrating a high Angiotensin I converting enzyme (ACE) inhibitory activity was purified and characterised. ACE inhibitory peptides were obtained from a two-step purification process: gel filtration and preparative reverse-phase high-performance chromatography (RP-HPLC) and then identified by mass spectrometer hybrid quadrupole-time-of-flight. A novel peptide GSGYF in the RBPH was firstly identified and found to have a partial sequence homology of Oryza sativa Japonica Group. This sequence was further synthesised to exhibit as good an inhibition potency with IC₅₀ value of 2.11 µg mL⁻¹ as Captopril (1.15 µg mL⁻¹). The cytotoxicity test revealed that this RBPH is non-toxic against Vero cells. In addition, the <50 kDa RBPH was resistant to in vitro digestion by pepsin and trypsin. These findings suggest that the RBPH containing ACE inhibitory peptides is likely to be safer and healthier than synthetic drugs and can be an effective food supplement for lowering blood pressure.     

酶法制备燕麦麸蛋白ACE抑制肽的研究

采用碱溶酸沉法制备了燕麦麸蛋白,并利用7种商业化蛋白酶对其进行酶解以考察生产ACE抑制肽的效果,结果表明Alcalase为最适用酶。优化了Alcalase水解燕麦麸蛋白的工艺条件,在[S]=5.0%,E/S=1.33%,pH7.5,温度60℃条件下酶解90min,酶解产物的ACE抑制活性最强(IC50=0.291mg/mL),此时水解度为11.0%,产物的相对分子质量主要集中在880Da以下。     

卵白蛋白多肽的酶解制备及抗氧化活性研究

以DPPH自由基清除率和水解度为指标,采用碱性蛋白酶酶解卵白蛋白制备抗氧化活性肽,考察底物质量分数、酶解时间、加酶量、温度等因素对制备的影响。正交实验结果表明,碱性蛋白酶的最佳水解条件为:底物质量分数4%、酶解时间6h、加酶量5500U/g,温度65℃,此条件下DPPH自由基清除率达到96.92%、水解度为57.14%。酶解时间对DPPH自由基清除率的影响最大,而底物质量分数对水解度的影响最大。      

Angiotensin I-converting enzyme inhibitory activity of peptides derived from egg white proteins by enzymatic hydrolysis

The hydrolysis of crude egg white with pepsin, trypsin, and chymotrypsin produced peptides with angiotensin-converting enzyme (ACE) inhibitory properties. These peptides were mainly derived from the proteolysis of ovalbumin. The most active hydrolysates were obtained after treatment with pepsin (50% inhibitory concentration [IC50], 55.3 microg/ml), with the fraction having a molecular mass lower than 3,000 Da giving the highest ACE inhibitory activity (IC50, 34.5 microg/ml). Nine subfractions were collected from the fraction with a molecular mass lower than 3,000 Da using semipreparative reversed-phase high-performance liquid chromatography. Considerable ACE inhibitory activity (IC50 < 40 microg/ml) was found in three of them. These subfractions were analyzed by reversed-phase high-performance liquid chromatography-tandem mass spectrometry, and 14 peptides were identified. These sequences were synthesized, and their ACE inhibitory activities were measured. Among the identified peptides, two novel sequences with potent ACE inhibitory activity were found. The amino acid sequences of these inhibitors were identified as Arg-Ala-Asp-His-Pro-Phe-Leu and Tyr-Ala-Glu-Glu-Arg-Tyr-Pro-Ile-Leu and showed IC50 values of 6.2 and 4.7 microM, respectively.     

Calcium binding of peptides derived from enzymatic hydrolysates of whey protein concentrate

This study was carried out to investigate the peptides derived from enzymatic hydrolysates of whey protein concentrate. The physiological activity of peptides in whey protein may be used in food additives to promote the absorption of calcium and prevent bone disorders. The whey protein was hydrolysed by trypsin, and the separation of peptides, the properties of hydrolysates and the analysis of the ability to inhibit the formation of calcium phosphates were then investigated. Calcium-binding peptides were produced by tryptic hydrolysis of whey protein concentrate and further purified by precipitation and chromatography on DEAE-cellulose. The hydrolysates were loaded onto an ion-exchange column, followed by stepwise elution with 0, 0.25, 0.5, and 0.75 m NaCl in equilibration buffer to separate the peptides. Trypsin hydrolysates were shown to peak with 0.25 m NaCl and 0.5 m NaCl. The results of SDS-PAGE analysis showed that the peptides with a small molecular weight of about 1.4 to 3.4 kDa were present in the fraction resulting from 0.25 m and 0.5 m NaCl stepwise elution by ion-exchange chromatography of tryptic hydrolysates. The results of this study show that the whey protein hydrolysates produced by the action of trypsin have the ability to inhibit the formation of calcium phosphates.     

Purification and identification of angiotensin converting enzyme inhibitory peptides from beef hydrolysates

Sarcoplasmic protein extracts from beef rump (biceps femoris) were hydrolyzed (for 0, 4, 8, 12, and 24 h) with three enzymes or their paired combinations. Ultrafiltration, gel-filtration, and RP-HPLC were used to separate angiotensin converting enzyme (ACE) inhibitory peptides from the hydrolysates. The highest ACE inhibitory activity of enzyme hydrolysates resulted from 4 h incubation with enzymes or their paired combinations. The activities of gel filtrated fractions from these hydrolysates were assayed in vitro, demonstrating that the 3rd peak of enzyme thermolysin + proteinase A hydrolysate had the highest ACE inhibition activity (52.8%). The 3rd peak of this hydrolysate was separated by RP-HPLC into five peaks, of which peak 3 showed 30.1% ACE inhibition activity. Its peptide sequence was determined to be Val-Leu-Ala-Gln-Tyr-Lys. The results suggested that this peptide may be a potent ACE inhibitor which might perhaps be used to develop beef with a bioactive peptide to lower blood pressure.     

源于食品蛋白质的血管紧张素Ⅰ转换酶抑制肽

血管紧张素I转换酶(ACE)是一种重要的血压调节因子,该酶的一些抑制剂有较好的降压效果,并作为预防和治疗高血压的食品和药物被广泛地使用。本文对不同食品来源的ACE抑制肽降压机理、结构和功能关系、应用前景进行了概述。     

Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir

In this study, a potent angiotensin-converting enzyme (ACE)-inhibitory activity was found in a commercial kefir made from caprine milk. The low molecular mass peptides released from caseins during fermentation were mainly responsible for this activity. Sixteen peptides were identified by HPLC-tandem mass spectrometry. Two of these peptides, with sequences PYVRYL and LVYPFTGPIPN, showed potent ACE-inhibitory properties. The impact of gastrointestinal digestion on ACE-inhibitory activity of kefir peptides was also evaluated. Some of these peptides were resistant to the incubation with pepsin followed by hydrolysis with Corolase PP. The ACE-inhibitory activity after simulated digestion was similar to or slightly lower than unhydrolyzed peptides, except for peptide β-casein f(47-52) (DKIHPF), which exhibited an activity 8 times greater after hydrolysis.     

Isolation and identification of angiotensin-converting enzyme inhibitory peptides from egg white protein hydrolysates

The aim of this study was to identify potential angiotensin I-converting enzyme (ACE) inhibitory peptide from egg white protein. The protein was hydrolysed by Alcalase and the hydrolysates were isolated with Gel filtration to get the high activity fraction. The fraction was identified by LC tandem mass spectrometric 4000 Q Trap MS. In the current work, 19 peptides were discovered in the fractions, five of which sourced from ovotransferrin and were synthesised by Fmoc solid phase method. ACE-inhibitory activity was measured by HPLC assay. The 50% inhibitory concentrations of Arg–Val–Pro–Ser–Leu (RVPSL) was 20 μM. Based on this remarkable ACE-inhibitory activity, it is suggested that RVPSL may have potential applications as a functional food, which could be used as nutraceutical compounds.     

Purification and characterisation of angiotensin I converting enzyme inhibitory peptides from lysozyme hydrolysates

Hen egg white lysozyme (HEWL) was hydrolysed with trypsin, papain and a combination of the two. The prepared hydrolysates exhibited ACE inhibitory activity. The hydrolysates were fractionated using ultrafiltration and reverse phase-high performance liquid chromatography (RP-HPLC). Three fractions, which showed the highest ACE inhibitory activities, were purified by RP-HPLC. They were the F₇ (from papain-trypsin hydrolysate), F₈ (from papain hydrolysate) and F₃ (from trypsin hydrolysate) fractions. The IC₅₀ values were 0.03, 0.155 and 0.23 mg/ml for F₇, F₈ and F₃, respectively. The F₇ fraction was the most potent ACE inhibitor peptide, and was composed of 12 amino acids, Phe-Glu-Ser-Asn-Phe-Asn-Thr-Gln-Ala-Thr-Asn-Arg (MW: 1428.6 Da). Lineweaver-Burk plots suggest that the F₇ peptide acts as an uncompetitive inhibitor against ACE. The kinetic parameters (K_m, V_max, and K_i) for the F₇ peptide were measured and compared to the control.     

Novel angiotensin I-converting enzyme inhibitory peptides derived from soya milk

Inhibitors of angiotensin I-converting enzyme (ACE) are useful in treating hypertension, and many have been derived from food products, including soybeans. Using the industrial protease PROTIN SD-NY10, we developed a processed soya milk (PSM) with enhanced ACE inhibitory activity. The ACE inhibitory activity of PSM (IC₅₀ = 0.26 μg/ml) was greater than that of regular soya milk (IC₅₀ = 8.75 μg/ml). Eight novel ACE inhibitory peptides were purified from PSM by reversed-phase chromatography: FFYY (IC₅₀,1.9 μM), WHP (4.8 μM), FVP (10.1 μM), LHPGDAQR (10.3 μM), IAV (27.0 μM), VNP (32.5 μM), LEPP (100.1 μM), and WNPR (880.0 μM). The IC₅₀ values of these peptides are comparable to those reported for other ACE inhibitory peptides derived from wheat, chicken, bonito, wine, etc. Due to the relatively low IC₅₀ values of several peptides identified in this study, they may serve as ideal base components of food supplements for patients with hypertension.     

Angiotensin-I-converting enzyme and prolyl endopeptidase inhibitory peptides from natural sources with a focus on marine processing by-products

Like many natural resource-based processing industries, the seafood processing sector gives rise to a significant volume of organic waste. Environmental issues, economic concerns and legal restrictions regarding the disposal of processing wastes have led to increased research in the discovery of alternative value-added products, such as bioactive peptides from these waste streams. Bioactive peptides have various physiological functionalities in the human body following consumption and these include antihypertensive, antiamnesiac, mineral-binding, immunodulatory, antioxidative and antithrombotic activities. The search for bioactive peptides from a variety of different sources has become a major area of research with potential for the functional foods sector. The isolation of bioactive peptides typically involves the hydrolysis of the protein of choice with different proteolytic enzymes, alone or in combination with Generally Recognised as Safe (GRAS) micro-organisms.     

鹅血红蛋白抗氧化活性肽的制备及工艺研究

以新鲜鹅血为原料提取血红蛋白,利用碱性蛋白酶、中性蛋白酶及风味蛋白酶来酶解鹅血红蛋白,采用甲醛滴定法测定鹅血红蛋白水解液的水解度,通过研究水解液对DPPH自由基清除能力来检测水解产物的抗氧化活性,并分析了酶解温度、时间、pH及酶与底物比对鹅血红蛋白水解产物的影响.结果表明,采用中性蛋白酶获得的酶解产物抗氧化活性最高.在中性蛋白酶的作用下,通过单因素及正交实验,优化出产物抗氧化活性较高的酶解工艺条件:温度50℃,酶解时间8h,pH7.0,酶与底物比8000U/g,在最佳酶解条件下,产物对DPPH自由基的清除率为89.6％.     

鹅血红蛋白抗氧化活性肽的制备及工艺研究

以新鲜鹅血为原料提取血红蛋白,利用碱性蛋白酶、中性蛋白酶及风味蛋白酶来酶解鹅血红蛋白,采用甲醛滴定法测定鹅血红蛋白水解液的水解度,通过研究水解液对DPPH自由基清除能力来检测水解产物的抗氧化活性,并分析了酶解温度、时间、pH及酶与底物比对鹅血红蛋白水解产物的影响。结果表明,采用中性蛋白酶获得的酶解产物抗氧化活性最高。在中性蛋白酶的作用下,通过单因素及正交实验,优化出产物抗氧化活性较高的酶解工艺条件:温度50℃,酶解时间8h,pH7.0,酶与底物比8000U/g,在最佳酶解条件下,产物对DPPH自由基的清除率为89.6%。      

Purification and characterisation of angiotensin I converting enzyme (ACE) inhibitory peptides derived from enzymatic hydrolysate of ovotransferrin

Three novel peptides, IQW, IRW and LKP, were predicted in our previous study in the thermolysin–pepsin ovotransferrin hydrolysate. The aims of the present study were to purify the peptides, and determine if the predicted peptides purified from the hydrolysate would have the same activity as the synthetic ones. We also determined the stability of the peptides under simulated gastrointestinal condition. IQW, IRW and LKP were then successfully purified from crude ovotransferrin hydrolysate through multi-step chromatographic purification comprising of cation exchange chromatography followed by three-step reverse-phase high performance liquid chromatography (RP-HPLC), and their sequences were analysed by UPLC-MS/MS. Our results showed that their activities were comparable to the synthetic ones. Simulated gastrointestinal incubation showed that IRW was degraded into a dipeptide of IR and a free amino acid of W by pancreatin, LKP was degraded into a dipeptide of KP and a free amino acid of L by mucosal peptidase, while IQW was stable against the digestive enzymes.     

Angiotensin I-converting enzyme inhibitory activity of enzymatic hydrolysates of goat milk protein fractions

Casein and whey protein fractions from goat milk were hydrolysed by subtilisin and trypsin, individually and in combination, to release angiotensin converting enzyme (ACE)-inhibitory peptides. Selected hydrolysates were fractionated by size exclusion chromatography (SEC) and further characterised. The highest ACE-inhibitory activity was obtained from the casein fraction hydrolysed by the combination of enzymes. SEC presented 4 fractions with fraction F2 (<2.3 kDa) containing the highest concentration of peptides and the highest activity. F2 contained a number of peptides not previously identified from caprine caseins but with structural similarity to other ACE-inhibitory peptides. The most active fraction in relation to protein content was F4 with IC₅₀ between 9.3 and 5.1 μg mL⁻¹. This fraction contained a compound tentatively identified as WY, an active dipeptide not previously reported from caseins. The high inhibitory capacity of these fractions points towards the advantage of implementing a membrane process to concentrate the most active peptides.     

扁杏仁肽对血管紧张素转化酶的抑制作用研究

采用碱溶酸沉法从陕北扁杏仁制得杏仁总蛋白,并采用Osborne法分级制备清蛋白、醇溶蛋白、球蛋白和谷蛋白;用碱性蛋白酶Alcalase水解,超滤分离,制备不同分子量总蛋白杏仁肽和分级蛋白杏仁肽;利用高效液相色谱法测定水解物,系统研究杏仁肽对血管紧张素转化酶(ACE)的抑制活性。结果表明,不同分子量的总蛋白杏仁肽均具有ACE抑制活性,且肽段分子量越小,抑制活性越强;分级蛋白杏仁肽中,谷蛋白肽的抑制活性最强,分子量低于1 ku的谷蛋白肽的IC50值为(96.21±0.06)μg/m L。      

食源蛋白制备血管紧张素抑制肽的研究进展

血管紧张素转化酶(angiotensin I converting enzyme,简称ACE)对于人体血压的调节有着十分重要的作用。血管紧张素转化酶抑制肽(ACEIP)是从食源性蛋白质中提取的功能性肽,有着抑制ACE的作用,从而降低人体血压,达到治疗高血压的目的。本文主要从ACE抑制肽的降压原理、来源、结构、分类及作用特点和前景展望这几方面对其进行总结阐述。